NxThera Completes $12.6 Million in Series B Financing for Treating BPH
NxThera Inc., a St. Paul, Minn.-based privately held medical devices company, has added $12.6 million in Series B financing.
NxThera Inc., a St. Paul, Minn.-based privately held medical devices company, has added $12.6 million in Series B financing.
Urology and women’s health have been areas of substantial M&A activity during the last 10 years as the major medtech consolidators have been busy building separate business units to address these medical needs.
OneMedPlace is pleased to announce panelists at the 4th annual OneMedForum business development and investment conference January 11-13th in San Francisco.
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
Voiding the bladder is one of the most basic human functions, so mundane that we pay it little mind most of the time.
Harvey Homan, President and CEO of Urovalve, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
HealthTronics announced that it has entered into a definitive merger agreement with Endocare.
Researchers found that Dendreon’s immunotherapy drug Provenge prolonged the lives of advanced prostate cancer patients by an average of 4.1 months compared to a placebo.
Two strong players in the surgical-instrument field have joined forces. Microline PENTAX, a leading manufacturer of reposable surgical instruments for laparoscopic procedures, has acquired California-based Starion Instruments, a developer of instruments to arrest bleeding during surgical procedures.
Copyright © 2024 | WordPress Theme by MH Themes